FOR IMMEDIATE RELEASE
DENVER, UNITED STATES – June 14, 2026 — The Orthobiologic Institute (TOBI) is gearing up to host its premier PRP and Regenerative Medicine Symposium, branded as IOF-MAX for its 2026 edition, commencing on June 17 in Denver, Colorado. This highly anticipated event is poised to serve as a pivotal platform for medical professionals to delve into the latest research, clinical applications, and technological innovations in Platelet-Rich Plasma (PRP) and other cutting-edge regenerative medicine treatments for musculoskeletal conditions.
Unveiling the Future of Regenerative Therapies
The IOF-MAX 2026 symposium will showcase a comprehensive exploration of the orthobiologics landscape, with dedicated sectors focusing on critical advancements. Attendees will gain insights into the latest in Platelet-Rich Plasma (PRP) Therapies & Applications, covering preparation techniques, clinical protocols, efficacy across various musculoskeletal conditions, and emerging uses. Discussions will encompass centrifugation systems, activation methods, and patient selection criteria, ensuring a deep dive into practical applications.
Beyond PRP, the event will extensively cover Regenerative Medicine & Interventional Orthobiologics. This broader spectrum includes stem cell therapies—from bone marrow concentrate to adipose-derived stem cells—as well as exosome therapies and growth factors. A significant emphasis will be placed on interventional techniques for precise biologic delivery, featuring musculoskeletal ultrasound-guided injections and advanced interventional spine biologics. The symposium's commitment to rigorous scientific inquiry and practical application is set to shape the future of orthobiologic treatments.
A Hub for Innovation and Professional Advancement
As a distinguished organization, The Orthobiologic Institute (TOBI) is renowned for its commitment to educating and empowering physicians through shared research, established best practices, and ongoing networking. The IOF-MAX 2026 symposium will continue this legacy, attracting a specialized audience of physicians, clinicians, researchers, and industry stakeholders involved in orthobiologics, sports medicine, pain management, and orthopedic surgery. Key highlights will include scientific sessions presenting cutting-edge research, expert-led workshops on advanced injection techniques, and interactive panel discussions featuring global leaders in the field.
The event offers significant B2B trade value, providing a highly concentrated platform for exhibitors to engage directly with decision-makers and practitioners actively seeking the latest orthobiologic products, technologies, and services. For professional buyers, IOF-MAX 2026 presents an unparalleled opportunity for comprehensive education, hands-on training, and direct interaction with innovators, enabling them to evaluate new products and integrate advanced regenerative therapies into their practices. Attendees are encouraged to visit the official website to explore the full program and register: https://interventionalorthobiologics.org/iof-max/
###
About The Orthobiologic Institute - TOBI PRP and Regenerative Medicine Symposium
The Orthobiologic Institute (TOBI) PRP and Regenerative Medicine Symposium, with its 2026 edition branded as IOF-MAX, is a premier annual event dedicated to advancing the field of orthobiologics. For over a decade, TOBI has hosted these conferences, serving as a critical gathering point for global thought-leaders to share research, establish best practices, and foster a collaborative environment. The symposium's mission is to promote a high-quality, standardized approach to biologic treatments, driving innovation and transforming healing practices in regenerative medicine.
Media Contact
Contact Name: Media Relations
Company: The Orthobiologic Institute - TOBI PRP and Regenerative Medicine Symposium Press Office
Email: [email protected]